US 6,335,028 B1 · Implantable particles for urinary incontinence

Abstract

The invention encompasses the treatment of urinary incontinence, gastroesophageal reflux disease and the amelioration of skin wrinkles using biocompatible hydrophilic cationic microparticles and a cell adhesion promoter.

Claims0

Dependent claims

Claims aren’t available for this document.

Facts

Application

09/263,773Filed 5 Mar 1999

Granted

1 Jan 2002

Term ends

Not estimatedThe source records don’t support an estimate.

Classification17 codes

A61K 9/0034
Galenical forms characterised by the site of application: urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder;…
A61K 9/1635
Organic macromolecular compounds: obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, polyacrylates
A61K 9/1641
Organic macromolecular compounds: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene…
A61K 47/62
The non-active ingredient being a modifying agent: the modifying agent being a protein, peptide or polyamino acid

Implantable particles for urinary incontinence

Life of this patent

Abstract

Claims0

Implantable particles for urinary incontinence

Life of this patent

Abstract

Claims0